Global Healthcare CMO Market (2019-2023...
Transcript of Global Healthcare CMO Market (2019-2023...
Global Healthcare CMO Market
(2019-2023 Edition)
April 2019
Global Healthcare CMO Market : Coverage
Executive Summary and Scope
Introduction/Market Overview
Global Market Analysis
Regional Analysis
Competitive Landscape
Company Profiles
Global Healthcare CMO Market : Coverage
Attributes Details
Title Global Healthcare CMO Market (2019-2023 Edition)
Coverage Global and Regional
Forecast Period of Market 2019-2023
Competition in the Market Fragmented
Key Players Catalent Pharma Solution, Recipharm, Aurobindo Pharma Ltd. and Boehringher Ingelheim
Scope of the Report
Global Healthcare CMO Market
An outsourcing in which a pharmaceutical firm contacts with a third party (contract manufacturing organization) for the manufacturing ofcomponents of its product or whole of its product is known as contract manufacturing. A contract manufacturing organization (CMO)undertakes the production of product(s) under the brand name of another firm.
A firm either big or mid-size select a CMO for primarily two reasons: it wants to shift (or cut) its cost and focus to its core activities, or thedevelopment of its products require special or expert handling.
CMOs provide independent manufacturing services in healthcare sector also. Healthcare CMOs can be segmented into pharmaceutical CMOsand medical device CMOs. After the discovery of chemical formula of a new drug, the pharmaceutical CMOs are given the task ofmanufacturing it into a whole product, so that the pharmaceutical companies are able to sell it into the market under their brand name. Servicesoffered by pharmaceutical CMOs can be divided into two main activities: primary manufacturing (Active Pharmaceutical Ingredients) andsecondary manufacturing (Finished Dosage Formulation). Contract manufacturing for medical devices is one of the fastest growing segments ofthe medical device industry, as companies are in the race to bring new devices to the market.
The global healthcare CMO market has recorded continuous growth over the past few years and is expected to follow the same trend in comingyears. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvalsand outsourcing of NMEs, innovations and increased regulatory pressure on quality. Yet there are some challenges, which healthcare CMOindustry faces, such as fragmented nature of market, less preference for outsourcing of profitable and biological drugs by big pharmaceuticalcompanies.
Executive Summary
Healthcare CMO Market : Global Analysis
Global Healthcare CMO Market by Value
The global healthcare CMO market value was US$.... billion in 2018. The global healthcare CMO market is anticipated to rise up to US$.... billion by 2023 as compared to US$....billion in 2019, representing a CAGR of ….% over the years 2019 to 2023.
CAGRs
2019-2023 xx%
2014 2015 2016 2017 2018
US
$ B
illio
n
2019 2020 2021 2022 2023
US
$ B
illio
n
Healthcare CMO : Global Analysis
Global Healthcare CMO Market by Segments; 2018
Medical Device CMO , xx%
Pharmaceutical CMO, xx%
Healthcare CMO Market : Segment Analysis
Global Medical Device CMO Market by Value; 2019-2023E (US$ Billion)
CAGRs
Medical Device CMO xx%
Pharmaceutical CMO xx%
2019 2020 2021 2022 2023
US
$ B
illio
n
Global Pharmaceutical CMO Market by Value; 2019-2023E (US$ Billion)
2019 2020 2021 2022 2023
US
$ B
illio
n
Pharmaceutical CMO Market : Global Analysis
Global Pharmaceutical CMO Market by Segments; 2018
Global Pharmaceutical CMO Market by Region; 2017
Active Pharmaceutical Ingredients
(API)
Finished Dosage Formulation (FDF)
Others
US
European Union
China
Japan
India
Brazil
Russia
South Korea
Others
Pharmaceutical CMO Market : Segment Analysis
Global Active Pharmaceutical Ingredient CMO Market by Value; 2019-2023E (US$ Billion)
CAGRs
Medical Device CMO xx%
Pharmaceutical CMO xx%
Global Finished Dosage Formulation CMO Market by Value; 2019-2023E (US$ Billion)
2019 2020 2021 2022 2023
US
$ B
illio
n
2019 2020 2021 2022 2023
US
$ B
illio
n
Healthcare CMO : Regional Analysis
The U.S. Pharmaceutical CDMO Market by Value;2019-2023E (US$ Billion)
India Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
Europe Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
2019 2020 2021 2022 2023
US
$ B
illio
n
2019 2020 2021 2022 2023
US
$ B
illio
n
2019 2020 2021 2022 2023
US
$ B
illio
n
China Pharmaceutical CDMO Market by Value; 2019-2023E (US$ Billion)
2019 2020 2021 2022 2023
US
$ B
illio
n
Global Healthcare CMO Market : Competitive Landscape
• Catalent Pharma Solution
• Recipharm
• Aurobindo Pharma Ltd.
• Boehringher Ingelheim
Players Profiled
Note: The graphs on this slide are only for sample representation.